AHA, others urge Supreme Court to bar excessive FCA penalties

The AHA, Pharmaceutical Research and Manufacturers of America, and U.S. Chamber of Commerce today urged the U.S. Supreme Court to bar civil monetary penalties under the False Claims Act that irrationally exceed the harm actually suffered by the government.